ArticleTranslational gastroenterology and hepatology2024
Selection between sunitinib and ripretinib using mutation analysis for gastrointestinal stromal tumor patients progressing on imatinib.
Heikki JoensuuPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.